生物
胰腺癌
基因敲除
免疫疗法
癌症研究
癌症
生物标志物
肿瘤科
内科学
免疫系统
免疫学
细胞培养
医学
遗传学
生物化学
作者
Hui Deng,Hanming Yao,Shurui Zhou,Chong He,Yuzhou Huang,Yunlong Li,Hanwei Chen,Jianchang Shu
标识
DOI:10.1016/j.mcp.2023.101948
摘要
Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant gastrointestinal tumors worldwide with a dismal prognosis and high relapse rate. PDAC is considered a "cold cancer" for which immunotherapy is not effective. Therefore, to improve the prognosis for PDAC patients, it is urgent to explore the mechanism driving its insensitivity to immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI